News, Articles & Resources
Cancer Research and Cancer Support Articles
FCS earns HITRUST i1 Certification, demonstrating strong cybersecurity and data protection practices across its pharmacy and data systems.
Women in their 20s and 30s, are receiving cancer diagnoses, and their cancer is often at more advanced stages. Learn More.
FCS physician abstract co-authors examine best practices to improve speed, efficiency & reduce cost in bringing anti-cancer medicines to patients.
Florida Cancer Specialists & Research Institute Welcomes
Board-certified Hematologist & Medical Oncologist Daniel Ezekwudo, MD, PhD To Charlotte County
Pluvicto is used to treat adults with prostate cancer that has progressed and who have already received other anticancer treatments.
Xofigo is used to treat prostate cancer that no longer responds to hormonal or surgical treatment that lowers testosterone.
Lutathera® is a targeted drug therapy approved for gastroenteropancreatic neuroendocrine tumors (GEP-NETs) that are positive for the hormone receptor somatostatin. Learn More.
Marcia Schmidt, MD, gynecologic oncologist joins Florida Cancer Specialists & Research Institute in Palm Beach County.
FCS Top News Updates
August 17, 2026
FCS Welcomes Arushi Thaper, MD to Orange County Team
August 10, 2026
FCS Welcomes Neel K. Gakhar, MD
August 4, 2026
FCS Expands Martin County Team with Elizabeth Blowers, MD, PhD
August 3, 2026
FCS Welcomes Nagapratap Ganta, MD and Aryanna Jordan, MD to Statewide Practice
FCS Achieves HITRUST i1 Certification to Manage Data Protection and Mitigate Cybersecurity ThreatsFCS earns HITRUST i1 Certification, demonstrating strong cybersecurity and data protection practices across its pharmacy and data systems.
Breast Cancer in the Millennial EraWomen in their 20s and 30s, are receiving cancer diagnoses, and their cancer is often at more advanced stages. Learn More.
FCS Physician Leaders Examine Best Practices To Improve Speed, Efficiency & Reduce Cost In Bringing Anti-cancer Medicines to PatientsFCS physician abstract co-authors examine best practices to improve speed, efficiency & reduce cost in bringing anti-cancer medicines to patients.
FCS Welcomes Daniel Ezekwudo, MD, PhDFlorida Cancer Specialists & Research Institute Welcomes Board-certified Hematologist & Medical Oncologist Daniel Ezekwudo, MD, PhD To Charlotte County
Pluvicto™ Treatment: What You Can ExpectPluvicto is used to treat adults with prostate cancer that has progressed and who have already received other anticancer treatments.
Xofigo® Treatment: What You Can ExpectXofigo is used to treat prostate cancer that no longer responds to hormonal or surgical treatment that lowers testosterone.
Lutathera® Treatment: What You Can ExpectLutathera® is a targeted drug therapy approved for gastroenteropancreatic neuroendocrine tumors (GEP-NETs) that are positive for the hormone receptor somatostatin. Learn More.
FCS Expands Specialized Gynecologic Oncology ServicesMarcia Schmidt, MD, gynecologic oncologist joins Florida Cancer Specialists & Research Institute in Palm Beach County.